المؤلفون: Fleisher AS; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA., Munsie LM; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA., Perahia DGS; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA., Andersen SW; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA., Higgins IA; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA., Hauck PM; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA., Lo AC; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA., Sims JR; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA., Brys M; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA., Mintun M; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA.

مؤلفون مشاركون: PERISCOPE-ALZ Site Investigators; From Eli Lilly and Company, Indianapolis, IN. Dr. A.C. Lo is currently at Kisbee Therapeutics, Cambridge, MA.

المصدر: Neurology [Neurology] 2024 Mar 12; Vol. 102 (5), pp. e208061. Date of Electronic Publication: 2024 Feb 22.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

مواضيع طبية MeSH: Alzheimer Disease*/diagnostic imaging , Alzheimer Disease*/drug therapy , Alzheimer Disease*/psychology, Aged ; Aged, 80 and over ; Female ; Humans ; Middle Aged ; Antibodies, Monoclonal/therapeutic use ; Bayes Theorem ; Disease Progression ; Double-Blind Method ; Treatment Outcome ; Male

المؤلفون: Sexton CE; Alzheimer's Association, Chicago, Illinois, USA., Bitan G; Department of Neurology, David Geffen School of Medicine, Brain Research Institute, Molecular Biology Institute, University of California Los Angeles (UCLA), Los Angeles, California, USA., Bowles KR; UK Dementia Research Institute at the University of Edinburgh, Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, UK., Brys M; Eli Lilly & Co., Indianapolis, Indiana, USA., Buée L; Univ Lille, Inserm, CHU-Lille, Lille Neuroscience and Cognition, LabEx DISTALZ, Place de Verdun, Lille, France., Maina MB; Sussex Neuroscience, School of Life Sciences, University of Sussex, Falmer, UK.; Biomedical Science Research and Training Centre, Yobe State University, Damaturu, Nigeria., Clelland CD; Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA., Cohen AD; University of Pittsburgh, School of Medicine, Department of Psychiatry and Alzheimer's disease Research Center, Pittsburgh, Pennsylvania, USA., Crary JF; Departments of Pathology, Neuroscience, and Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Dage JL; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Diaz K; CurePSP, Inc, New York, New York, USA., Frost B; Sam & Ann Barshop Institute for Longevity & Aging Studies Glenn Biggs Institute for Alzheimer's & Neurodegenerative Disorders Department of Cell Systems and Anatomy University of Texas Health San Antonio, San Antonio, Texas, USA., Gan L; Helen and Robert Appel Alzheimer Disease Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA., Goate AM; Department of Genetics & Genomic Sciences, Ronald M. Loeb Center for Alzheimer's disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Golbe LI; CurePSP, Inc, New York, New York, USA.; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA., Hansson O; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden., Karch CM; Department of Psychiatry, Washington University in St. Louis, St. Louis, Missouri, USA., Kolb HC; Janssen R&D, Neuroscience, San Diego, California, USA., La Joie R; Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA., Lee SE; Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA., Matallana D; Aging Institute, Neuroscience Program, Psychiatry Department, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.; Mental Health Department, Hospital Universitario Fundaciòn Santa Fe, Bogota, Colombia., Miller BL; Memory and Aging Center, Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, California, USA., Onyike CU; Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, Baltimore, Maryland, USA., Quiroz YT; Departments of Psychiatry and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Rexach JE; Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, University College London Institute of Neurology, Queen Square, London, UK., Rommel A; Rainwater Charitable Foundation, Fort Worth, Texas, USA., Sadri-Vakili G; Sean M. Healey &AMG Center for ALS at Mass General, Massachusetts General Hospital, Boston, Massachusetts, USA., Schindler SE; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA., Schneider JA; Rush Alzheimer's Disease Center, Chicago, Illinois, USA., Sperling RA; Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Teunissen CE; Neurochemistry Laboratory, Clinical Chemistry department, Amsterdam Neuroscience, Program Neurodegeneration, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Weninger SC; FBRI, Cambridge, Massachusetts, USA., Worley SL; Independent Science Writer, Bryn Mawr, Pennsylvania, USA., Zheng H; Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA., Carrillo MC; Alzheimer's Association, Chicago, Illinois, USA.

المصدر: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Mar; Vol. 20 (3), pp. 2240-2261. Date of Electronic Publication: 2024 Jan 03.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE

مواضيع طبية MeSH: Alzheimer Disease* , Tauopathies*, Humans ; tau Proteins

المؤلفون: Brys M; Laboratory of Veterinary Pathology, Department of Pathobiology, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium. Electronic address: Marieke.Brys@UGent.be., Claerebout E; Laboratory of Parasitology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium., Chiers K; Laboratory of Veterinary Pathology, Department of Pathobiology, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.

المصدر: Veterinary parasitology [Vet Parasitol] 2023 Dec; Vol. 324, pp. 110074. Date of Electronic Publication: 2023 Nov 10.

نوع المنشور: Randomized Controlled Trial, Veterinary; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7602745 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2550 (Electronic) Linking ISSN: 03044017 NLM ISO Abbreviation: Vet Parasitol Subsets: MEDLINE

مواضيع طبية MeSH: Psoroptidae* , Mite Infestations*/veterinary , Mites* , Lymphedema*/drug therapy , Lymphedema*/veterinary , Lymphedema*/pathology , Insecticides* , Horse Diseases*/drug therapy , Horse Diseases*/pathology, Animals ; Horses ; Belgium ; Prospective Studies ; Macrolides/therapeutic use ; Chronic Disease ; Pruritus/drug therapy ; Pruritus/veterinary

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Brys, M., Chiers, K.

المصدر: In Journal of Comparative Pathology April 2024 210:91-91

المؤلفون: Starska, K, Forma, E, Bryś, M, Głowacka, E, Lewy-Trenda, I, Łukomski, M, Krajewska, WM

المصدر: In Advances in Medical Sciences 1 June 2012 57(1):124-135

المؤلفون: Brys M; Laboratory of Veterinary Pathology, Department of Pathobiology, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium., Claerebout E; Laboratory of Parasitology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium., Chiers K; Laboratory of Veterinary Pathology, Department of Pathobiology, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.

المصدر: Veterinary sciences [Vet Sci] 2023 May 12; Vol. 10 (5). Date of Electronic Publication: 2023 May 12.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101680127 Publication Model: Electronic Cited Medium: Internet ISSN: 2306-7381 (Electronic) Linking ISSN: 23067381 NLM ISO Abbreviation: Vet Sci Subsets: PubMed not MEDLINE

المؤلفون: de Leon, M. J., Mosconi, L., Li, J., De Santi, S., Yao, Y., Tsui, W. H., Pirraglia, E., Rich, K., Javier, E., Brys, M., Glodzik, L., Switalski, R., Saint Louis, L. A., Pratico, D.

المصدر: Journal of Neurology: Official Journal of the European Neurological Society. December 2007 254(12):1666-1675

المؤلفون: Korneder J; Applied Behavior Analysis Autism Clinic, Oakland University, Rochester, Michigan, USA., Louie WG; Intelligent Robotics Laboratory, Oakland University, Rochester, Michigan, USA., Pawluk CM; Applied Behavior Analysis Autism Clinic, Oakland University, Rochester, Michigan, USA., Abbas I; Intelligent Robotics Laboratory, Oakland University, Rochester, Michigan, USA., Brys M; Applied Behavior Analysis Autism Clinic, Oakland University, Rochester, Michigan, USA., Rooney F; Applied Behavior Analysis Autism Clinic, Oakland University, Rochester, Michigan, USA.

المصدر: Assistive technology : the official journal of RESNA [Assist Technol] 2022 Nov 02; Vol. 34 (6), pp. 707-716. Date of Electronic Publication: 2021 May 28.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 8917250 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1949-3614 (Electronic) Linking ISSN: 10400435 NLM ISO Abbreviation: Assist Technol

مواضيع طبية MeSH: Autism Spectrum Disorder*/therapy , Robotics*/methods, Child ; Humans ; Language ; Learning

المؤلفون: Biglan K; Eli Lilly and Company, Indianapolis, Indiana, USA., Munsie L; Eli Lilly and Company, Indianapolis, Indiana, USA., Svensson KA; Eli Lilly and Company, Indianapolis, Indiana, USA., Ardayfio P; Eli Lilly and Company, Indianapolis, Indiana, USA., Pugh M; Eli Lilly and Company, Indianapolis, Indiana, USA., Sims J; Eli Lilly and Company, Indianapolis, Indiana, USA., Brys M; Eli Lilly and Company, Indianapolis, Indiana, USA.

المصدر: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2022 Mar; Vol. 37 (3), pp. 513-524. Date of Electronic Publication: 2021 Dec 02.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE

مواضيع طبية MeSH: Alzheimer Disease* , Lewy Body Disease*/drug therapy , Neuroprotective Agents*/therapeutic use, Cognition ; Double-Blind Method ; Humans